Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
Clinical trial NCT00365859 · COMPLETED
Trial details
- NCT number
- NCT00365859
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2009-06-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.